Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Supreme Cannabis Company Inc. (The) T.FIRE

Consumer Cyclical Healthcare Advertising Agencies Drug Manufacturers - Major
The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.


TSX:FIRE - Post by User

Supreme Cannabis Company Inc. (The) > Supreme Cannabis: Stifel-GMP Raises Price Target To $0.55
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(599)
•••
Comment by Bigginvestoron Feb 17, 2021 1:19pm
205 Views
Post# 32585881

RE:RE:Supreme Cannabis: Stifel-GMP Raises Price Target To $0.55

RE:RE:Supreme Cannabis: Stifel-GMP Raises Price Target To $0.55
Bigginvestor wrote:
AwareInvestor wrote:
Last week, The Supreme Cannabis Company announced its second quarter 2021 financial results. The company reported net revenues of C$18.3 million, an increase of 54% quarter over quarter, and EBITDA of C$3.6 million.

Supreme currently has four analysts covering the company with a weighted 12-month price target of C$0.41. This is up from the average before the results, which was C$0.21. One analyst has a buy rating, while the other three have hold ratings.





<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities